Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TOXR21Shares XRP ETF

CBOE · CIK 0002028835
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts36

Identity from submissions API

Name21Shares XRP ETF
CIK0002028835
TickersTOXR
ExchangesCBOE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6221 Commodity Contracts Brokers & Dealers
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone646-370-6016
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • 21Shares Core XRP Trust (2024-11-01T04:00:00.000Z → 2024-11-01T04:00:00.000Z)
Business address
477 MADISON AVENUE, 6TH FLOOR
NEW YORK
NY
10022
NY
Mailing address
477 MADISON AVENUE, 6TH FLOOR
NEW YORK
NY
10022
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

33 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-118093 333-282942 261541412 33 327704
2026-11-10 10-Q QUARTERLY REPORT 0001213900-26-118028 001-42966 261540499 34 2551952 1 1
2026-08-27 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-094061 333-282942 261324352 33 144106
2026-08-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-094019 333-282942 261323822 33 28751
2026-08-26 8-K CURRENT REPORT 1.01,5.03,9.01 0001213900-26-093987 001-42966 261323283 34 898622 1 1
2026-08-11 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-087875 333-282942 261264468 33 304014
2026-08-11 10-Q QUARTERLY REPORT 0001213900-26-087823 001-42966 261263852 34 2512484 1 1
2026-07-07 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-076065 333-282942 261160210 33 21554
2026-07-07 8-K CURRENT REPORT 1.02 0001213900-26-075988 001-42966 261159679 34 190297 1 1
2026-05-14 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-056714 333-282942 26979762 33 232237
2026-05-13 10-Q QUARTERLY REPORT 0001213900-26-055788 001-42966 26973229 34 2262384 1 1
2026-04-01 424I FORM 424I 0001213900-26-038424 333-282942 26827194 33 145255 1 1
2026-03-31 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-037102 333-282942 26819159 33 803472
2026-03-31 10-K ANNUAL REPORT 0001213900-26-036689 001-42966 26816464 34 3204133 1 1
2026-01-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-007760 333-282942 26561176 33 277923
2026-01-26 10-Q QUARTERLY REPORT 0001213900-26-007699 001-42966 26560546 34 2017073 1 1
2025-12-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003619 333-282942 251563389 33 1884
2025-12-10 424B3 PROSPECTUS 0001213900-25-120172 333-282942 251562750 33 1292085
2025-12-10 CERT CBOE BZX CERTIFICATION 0001417835-25-000276 001-42966 251561436 34 159998
2025-12-09 CORRESP filename1.htm 0001213900-25-119771 8275
2025-12-08 CORRESP filename1.htm 0001213900-25-118927 13164
2025-12-08 S-1/A AMENDMENT NO. 5 TO FORM S-1 0001213900-25-118924 333-282942 251554545 33 1592427
2025-12-05 UPLOAD filename1.pdf 0000000000-25-011333 333-282942 45648
2025-11-20 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001213900-25-112826 333-282942 251500950 33 1979712
2025-11-20 CORRESP filename1.htm 0001213900-25-112828 8251
2025-11-19 8-A12B FORM 8-A12B 0001213900-25-112696 001-42966 251500057 34 15792
2025-11-07 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-25-107665 333-282942 251463447 33 2744325
2025-10-10 CORRESP filename1.htm 0001213900-25-098142 19317
2025-10-10 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-098141 333-282942 251388367 33 1136727
2025-09-18 UPLOAD filename1.pdf 0000000000-25-010193 333-282942 47386
2025-08-22 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-079981 333-282942 251247078 33 1189064 1 1
2024-11-08 UPLOAD filename1.pdf 0000000000-24-012483 333-282942 42480
2024-11-01 S-1 REGISTRATION STATEMENT 0001213900-24-093305 333-282942 241417975 33 1449188

Latest XBRL company facts

One latest value per concept from companyfacts (36 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 11.02M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-31 0001213900-26-036689
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3,946 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 244.52M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap Assets Assets USD 159.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap AssetsNet Net Assets USD 159.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 11.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -37.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -183,801 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 765,081 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-036689
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares -0.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure -0.003 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease Investment Company, Net Asset Value Per Share, Period Increase (Decrease) USD/shares -3.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare USD/shares -3.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 5.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-036689
us-gaap InvestmentIncomeNet Investment Income, Net USD -348,647 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 223.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 159.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap LegalFees Legal Fees USD 100,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2026-01-26 0001213900-26-007699
us-gaap Liabilities Liabilities USD 3,946 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 14.49 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -37.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap OperatingExpenses Operating Expenses USD 348,647 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap OtherLiabilities Other Liabilities USD 0 2025-09-30 2025 Q3 10-Q 2026-01-26 0001213900-26-007699
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -84.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 22.07 2024-12-20 2026 Q1 10-Q 2026-05-13 0001213900-26-055788
us-gaap SponsorFees Sponsor Fees USD 348,647 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 159.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD -50.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares -2.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 28.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 4.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -78.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -21.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001213900-26-118028

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →